Month: December 2012
Geriatric Opportunities In Pharmaceutical Product Development: What’s New? What’s Changed? What’s Needed?
This article focuses on three critical considerations in the planning and development of drugs targeted at the geriatric population that present enormous opportunities for the forward thinking life sciences companies. We highlight two current products Pradaxa and Xarelto and discuss the geriatric impact on them as examples of challenges the life sciences industries confront. In the last website posting, we looked at